CAPSTONE INVESTMENT ADVISORS, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q2 2022$1,000
-66.7%
12,5000.0%0.00%–
Q1 2022$3,000
-57.1%
12,5000.0%0.00%–
Q4 2021$7,0000.0%12,5000.0%0.00%–
Q3 2021$7,000
-30.0%
12,5000.0%0.00%–
Q2 2021$10,000–12,500–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders